{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:30:35Z","timestamp":1775025035113,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/nrendo.2009.147","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T07:29:56Z","timestamp":1250666996000},"page":"519-522","source":"Crossref","is-referenced-by-count":28,"title":["Nonfunctioning pituitary adenomas: the Oxford experience"],"prefix":"10.1038","volume":"5","author":[{"given":"John A. H.","family":"Wass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrendo2009147_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat, S.  et al. The prevalence of pituitary adenomas: a systematic review. Cancer 101, 613\u2013619 (2004).","journal-title":"Cancer"},{"key":"BFnrendo2009147_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/rep.0.1210363","volume":"121","author":"JR Davis","year":"2001","unstructured":"Davis, J. R.  et al. Pituitary tumours. Reproduction 121, 363\u2013371 (2001).","journal-title":"Reproduction"},{"key":"BFnrendo2009147_CR3","first-page":"1420","volume":"85","author":"B Nilsson","year":"2000","unstructured":"Nilsson, B., Gustavsson-Kadaka, E., Bengtsson, B.-A. & Jonsson, B. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J. Clin. Endocrinol. Metab. 85, 1420\u20131425 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009147_CR4","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly, A. F.  et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91, 4769\u20134775 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009147_CR5","volume-title":"High prevalence of pituitary adenomas: a community-based study in the city of Banbury","author":"A Fernandez","year":"2008","unstructured":"Fernandez, A.  et al. High prevalence of pituitary adenomas: a community-based study in the city of Banbury. Presented at the British Endocrine Society meeting (2008)."},{"key":"BFnrendo2009147_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","volume":"65","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki, N.  et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin. Endocrinol. (Oxf.) 65, 524\u2013529 (2006).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR7","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1001\/jama.1990.03440200076026","volume":"263","author":"M Reincke","year":"1990","unstructured":"Reincke, M.  et al. The 'incidentaloma' of the pituitary gland. Is neurosurgery required? JAMA 263, 2772\u20132776 (1990).","journal-title":"JAMA"},{"key":"BFnrendo2009147_CR8","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2005-2552","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"Dekkers, O. M.  et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 1796\u20131801 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009147_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","volume":"67","author":"N Karavitaki","year":"2007","unstructured":"Karavitaki, N.  et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin. Endocrinol. (Oxf.) 67, 938\u2013943 (2007).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","volume":"48","author":"N Gittoes","year":"1998","unstructured":"Gittoes, N.  et al. Radiotherapy for non-functioning pituitary tumours. Clin. Endocrinol. (Oxf.) 48, 331\u2013337 (1998).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/bmj.304.6838.1343","volume":"304","author":"M Brada","year":"1992","unstructured":"Brada, M.  et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304, 1343\u20131346 (1992).","journal-title":"BMJ"},{"key":"BFnrendo2009147_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1365-2265.1999.00865.x","volume":"51","author":"HE Turner","year":"1999","unstructured":"Turner, H. E., Stratton, I. M., Byrne, J. V., Adams, C. B. & Wass, J. H. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation\u2014a follow-up study. Clin. Endocrinol. (Oxf.) 51, 281\u2013284 (1999).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR13","volume-title":"Prolonged post-operative follow-up is necessary for unirradiated non-functioning pituitary adenomata","author":"K Allen","year":"2006","unstructured":"Allen, K. & Wass, J. A. H. Prolonged post-operative follow-up is necessary for unirradiated non-functioning pituitary adenomata. Presented at the European Congress of Endocrinology (2006)."},{"key":"BFnrendo2009147_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJ Bradley","year":"2003","unstructured":"Bradley, K. J., Wass, J. A. & Turner, H. E. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin. Endocrinol. (Oxf.) 58, 59\u201364 (2003).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR15","first-page":"1368","volume":"83","author":"U Renner","year":"1998","unstructured":"Renner, U.  et al. Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 83, 1368\u20131375 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009147_CR16","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1210\/jc.2003-030859","volume":"89","author":"R Pivonello","year":"2004","unstructured":"Pivonello, R.  et al. Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J. Clin. Endocrinol. Metab. 89, 1674\u20131683 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2009147_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2265.2005.02295.x","volume":"63","author":"Y Greenman","year":"2005","unstructured":"Greenman, Y.  et al. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin. Endocrinol. (Oxf.) 63, 39\u201344 (2005).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2009147_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11154-008-9086-0","volume":"10","author":"A Saveanu","year":"2009","unstructured":"Saveanu, A. & Jaquet, P. Somatostatin-dopamine ligands in the treatment of pituitary adenomas. Rev. Endocr. Metab. Disord. 10, 83\u201390 (2009).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"BFnrendo2009147_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11154-008-9107-z","volume":"10","author":"AM Colao","year":"2009","unstructured":"Colao, A. M.  et al. Medical therapy of pituitary adenomas: effects on tumor shrinkage. Rev. Endocr. Metab. Disord. 10, 111\u2013123 (2009).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"BFnrendo2009147_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1677\/ERC-08-0181","volume":"15","author":"AM Colao","year":"2008","unstructured":"Colao, A. M. Medical therapy for clinically non-functioning pituitary adenomas. Endocr. Relat. Cancer 15, 905\u2013915 (2008).","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:31:38Z","timestamp":1684467098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BFnrendo2009147"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.147","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}